Rhythm Pharmaceuticals buy Citigroup Inc.
Start price
17.03.26
/
50%
€77.50
Target price
17.03.27
€113.94
Performance (%)
5.81%
Price
09:32
?
Summary
This prediction is currently active. With a performance of 5.81%, the BUY prediction by Citigroup_Inc_ for Rhythm Pharmaceuticals is trending in the right direction. This prediction currently runs until 17.03.27. The prediction end date can be changed by Citigroup_Inc_ at any time. Citigroup_Inc_ has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m |
|---|---|---|
| Rhythm Pharmaceuticals | 17.391% | 17.391% |
| iShares Core DAX® | 0.423% | 5.706% |
| iShares Nasdaq 100 | 4.096% | 16.639% |
| iShares Nikkei 225® | 4.469% | 18.343% |
| iShares S&P 500 | 1.788% | 9.644% |
Comments by Citigroup_Inc_ for this prediction
In the thread Rhythm Pharmaceuticals diskutieren
Rhythm Pharmaceuticals (RYTM) had its price target lowered by Citigroup Inc. from $136.00 to $131.00. They now have a "buy" rating on the stock.
Ratings data for RYTM provided by MarketBeat
Stopped prediction by Citigroup_Inc_ for Rhythm Pharmaceuticals
Rhythm Pharmaceuticals
Start price
Target price
Perf. (%)
€93.00
27.11.25
27.11.25
€117.12
27.11.26
27.11.26
-11.83%
09:32
09:32
